M11.2
Other chondrocalcinosis
Clinical Classification Guidelines
Inclusion Terms
- Chondrocalcinosis NOS
Medical Intelligence & Overview
Chondrocalcinosis, classified under ICD-10 code M11.2, is a joint condition characterized by the abnormal deposits of calcium pyrophosphate dihydrate (CPPD) crystals within the cartilage. These deposits lead to cartilage degeneration and can cause joint pain, swelling, and reduced mobility. Often referred to when the specific location or cause is undetermined, this form of chondrocalcinosis is also known as 'other chondrocalcinosis' or 'Chondrocalcinosis NOS.' While it primarily affects older adults, the severity and presentation can vary widely among individuals. Recognizing the signs and understanding possible causes can assist in managing symptoms effectively.
Causes & Symptoms
Clinical Causes: Aging process leading to calcium crystal buildup in the joints Joint trauma or injury that damages cartilage and facilitates crystal deposition Genetic predispositions influencing cartilage metabolism and crystal formation Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Other underlying joint diseases or conditions that alter cartilage integrity
Key Symptoms: Joint pain, particularly during movement or after periods of rest Swelling and tenderness around affected joints Reduced range of motion due to joint discomfort Possible warmth or redness in the area of the affected joint Episodes of acute joint inflammation resembling gout attacks
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chondrocalcinosis involves a combination of clinical examination and imaging studies. Key diagnostic steps include: - Physical assessment to evaluate joint swelling, tenderness, and range of motion - Imaging techniques, primarily X-rays, to detect calcium deposits within cartilage - Joint fluid analysis via arthrocentesis to identify CPPD crystals under polarized light microscopy - Blood tests to check for metabolic disorders or other underlying conditions These methods help confirm the presence of calcium deposits and rule out other joint diseases such as gout or osteoarthritis.
Treatment Protocols: Management of chondrocalcinosis focuses on alleviating symptoms and addressing underlying causes where possible. Treatment options include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Colchicine, especially during acute flare-ups, to decrease crystal formation and joint inflammation - Corticosteroid injections directly into affected joints for severe inflammation - Physical therapy to improve joint function and strengthen supporting muscles - Lifestyle modifications, such as weight management and avoiding joint stress - Monitoring and managing metabolic conditions contributing to crystal deposition While there is no cure for chondrocalcinosis, these interventions aim to improve quality of life and function.
Clinical Advice & FAQs
Billing Guidance
Is M11.2 a billable ICD-10 code?
Yes, M11.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.2?
Clinical documentation must specify the nature of Other chondrocalcinosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference